nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—DDC—embryo—gestational diabetes	0.0966	0.118	CbGeAlD
Droxidopa—ADRB3—adipose tissue—gestational diabetes	0.0873	0.106	CbGeAlD
Droxidopa—PAH—head—gestational diabetes	0.0858	0.105	CbGeAlD
Droxidopa—Epinephrine—TNF—gestational diabetes	0.0593	1	CrCbGaD
Droxidopa—DDC—head—gestational diabetes	0.0489	0.0597	CbGeAlD
Droxidopa—SLC16A10—adipose tissue—gestational diabetes	0.0437	0.0533	CbGeAlD
Droxidopa—ADRA1B—head—gestational diabetes	0.0386	0.047	CbGeAlD
Droxidopa—ADRA1D—head—gestational diabetes	0.0377	0.046	CbGeAlD
Droxidopa—SLC16A10—vagina—gestational diabetes	0.0363	0.0443	CbGeAlD
Droxidopa—ADRB1—adipose tissue—gestational diabetes	0.0357	0.0435	CbGeAlD
Droxidopa—ADRA2A—islet of Langerhans—gestational diabetes	0.0337	0.041	CbGeAlD
Droxidopa—ADRA1A—adipose tissue—gestational diabetes	0.0282	0.0344	CbGeAlD
Droxidopa—ADRA2C—uterus—gestational diabetes	0.0275	0.0335	CbGeAlD
Droxidopa—ADRB1—head—gestational diabetes	0.0274	0.0334	CbGeAlD
Droxidopa—ADRA2C—adipose tissue—gestational diabetes	0.0269	0.0328	CbGeAlD
Droxidopa—SLC6A2—head—gestational diabetes	0.0233	0.0284	CbGeAlD
Droxidopa—ADRA2C—vagina—gestational diabetes	0.0224	0.0273	CbGeAlD
Droxidopa—ADRA2A—uterus—gestational diabetes	0.0219	0.0268	CbGeAlD
Droxidopa—ADRA1A—head—gestational diabetes	0.0217	0.0264	CbGeAlD
Droxidopa—ADRA2A—adipose tissue—gestational diabetes	0.0215	0.0262	CbGeAlD
Droxidopa—ADRA2C—head—gestational diabetes	0.0207	0.0252	CbGeAlD
Droxidopa—ADRA2A—vagina—gestational diabetes	0.0178	0.0218	CbGeAlD
Droxidopa—ADRA2A—head—gestational diabetes	0.0165	0.0201	CbGeAlD
Droxidopa—PAH—Amino acid and derivative metabolism—GLS2—gestational diabetes	0.00757	0.0629	CbGpPWpGaD
Droxidopa—DDC—Tryptophan metabolism—CYP19A1—gestational diabetes	0.00601	0.0499	CbGpPWpGaD
Droxidopa—DDC—Amino acid and derivative metabolism—GLS2—gestational diabetes	0.0049	0.0407	CbGpPWpGaD
Droxidopa—PAH—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.00479	0.0398	CbGpPWpGaD
Droxidopa—ADRA1B—AMPK Signaling—LEPR—gestational diabetes	0.0037	0.0308	CbGpPWpGaD
Droxidopa—PAH—SIDS Susceptibility Pathways—AR—gestational diabetes	0.0034	0.0283	CbGpPWpGaD
Droxidopa—ADRA1A—AMPK Signaling—LEPR—gestational diabetes	0.00329	0.0273	CbGpPWpGaD
Droxidopa—DDC—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.0031	0.0257	CbGpPWpGaD
Droxidopa—DDC—Circadian rythm related genes—MTNR1B—gestational diabetes	0.00291	0.0242	CbGpPWpGaD
Droxidopa—DDC—Circadian rythm related genes—NAMPT—gestational diabetes	0.00254	0.0211	CbGpPWpGaD
Droxidopa—DDC—SIDS Susceptibility Pathways—AR—gestational diabetes	0.0022	0.0183	CbGpPWpGaD
Droxidopa—ADRA1B—AMPK Signaling—ADIPOQ—gestational diabetes	0.00209	0.0174	CbGpPWpGaD
Droxidopa—DDC—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.00208	0.0173	CbGpPWpGaD
Droxidopa—SLC16A10—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.00191	0.0159	CbGpPWpGaD
Droxidopa—ADRB3—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00188	0.0157	CbGpPWpGaD
Droxidopa—ADRA1A—AMPK Signaling—ADIPOQ—gestational diabetes	0.00186	0.0154	CbGpPWpGaD
Droxidopa—ADRB3—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.00161	0.0134	CbGpPWpGaD
Droxidopa—PAH—Metabolism—GGCT—gestational diabetes	0.00159	0.0132	CbGpPWpGaD
Droxidopa—SLC6A2—Monoamine Transport—TNF—gestational diabetes	0.00144	0.012	CbGpPWpGaD
Droxidopa—PAH—Metabolism—GLS2—gestational diabetes	0.00139	0.0115	CbGpPWpGaD
Droxidopa—ADRA1B—AMPK Signaling—LEP—gestational diabetes	0.0013	0.0108	CbGpPWpGaD
Droxidopa—DDC—Circadian rythm related genes—LEP—gestational diabetes	0.00129	0.0107	CbGpPWpGaD
Droxidopa—ADRB3—GPCR ligand binding—MTNR1B—gestational diabetes	0.00123	0.0102	CbGpPWpGaD
Droxidopa—ADRA1D—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00123	0.0102	CbGpPWpGaD
Droxidopa—ADRA2B—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.00119	0.00992	CbGpPWpGaD
Droxidopa—ADRA1A—AMPK Signaling—LEP—gestational diabetes	0.00115	0.00959	CbGpPWpGaD
Droxidopa—SLC6A2—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.00114	0.00947	CbGpPWpGaD
Droxidopa—PAH—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.00113	0.00941	CbGpPWpGaD
Droxidopa—ADRB1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00112	0.00929	CbGpPWpGaD
Droxidopa—ADRA2C—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.00112	0.00927	CbGpPWpGaD
Droxidopa—ADRA2B—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00111	0.00921	CbGpPWpGaD
Droxidopa—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00109	0.00909	CbGpPWpGaD
Droxidopa—ADRA1D—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.00105	0.00874	CbGpPWpGaD
Droxidopa—ADRA2C—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00104	0.0086	CbGpPWpGaD
Droxidopa—DDC—Metabolism—GGCT—gestational diabetes	0.00103	0.00855	CbGpPWpGaD
Droxidopa—ADRA1B—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.00102	0.00846	CbGpPWpGaD
Droxidopa—PAH—Disease—RBP4—gestational diabetes	0.00101	0.00842	CbGpPWpGaD
Droxidopa—SLC16A10—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000971	0.00807	CbGpPWpGaD
Droxidopa—ADRB1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000958	0.00796	CbGpPWpGaD
Droxidopa—ADRA2B—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.00095	0.00789	CbGpPWpGaD
Droxidopa—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000937	0.00779	CbGpPWpGaD
Droxidopa—PAH—Disease—NAMPT—gestational diabetes	0.00091	0.00755	CbGpPWpGaD
Droxidopa—ADRA2A—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000906	0.00753	CbGpPWpGaD
Droxidopa—ADRA1A—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000905	0.00752	CbGpPWpGaD
Droxidopa—PAH—Disease—GCK—gestational diabetes	0.000904	0.00751	CbGpPWpGaD
Droxidopa—DDC—Metabolism—GLS2—gestational diabetes	0.000899	0.00747	CbGpPWpGaD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000887	0.00737	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000873	0.00725	CbGpPWpGaD
Droxidopa—ADRA2A—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000841	0.00699	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—MTNR1B—gestational diabetes	0.000801	0.00665	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000775	0.00644	CbGpPWpGaD
Droxidopa—PAH—Metabolism—NAMPT—gestational diabetes	0.000762	0.00633	CbGpPWpGaD
Droxidopa—PAH—Metabolism—GCK—gestational diabetes	0.000757	0.00629	CbGpPWpGaD
Droxidopa—DDC—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.000732	0.00608	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—MTNR1B—gestational diabetes	0.00073	0.00606	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—MTNR1B—gestational diabetes	0.000723	0.00601	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.00072	0.00598	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—MTNR1B—gestational diabetes	0.000714	0.00593	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000695	0.00577	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—MTNR1B—gestational diabetes	0.000675	0.00561	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—MTNR1B—gestational diabetes	0.000665	0.00552	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—MTNR1B—gestational diabetes	0.000631	0.00524	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—MTNR1B—gestational diabetes	0.000591	0.0049	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000579	0.00481	CbGpPWpGaD
Droxidopa—PAH—Metabolism—CYP19A1—gestational diabetes	0.000553	0.0046	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—MTNR1B—gestational diabetes	0.000549	0.00456	CbGpPWpGaD
Droxidopa—DDC—Metabolism—NAMPT—gestational diabetes	0.000493	0.00409	CbGpPWpGaD
Droxidopa—DDC—Metabolism—GCK—gestational diabetes	0.00049	0.00407	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—LEPR—gestational diabetes	0.000472	0.00392	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000453	0.00376	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GGCT—gestational diabetes	0.000447	0.00371	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000412	0.00343	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—MTNR1B—gestational diabetes	0.000411	0.00341	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000409	0.00339	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000403	0.00335	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GLS2—gestational diabetes	0.000391	0.00325	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000382	0.00317	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000376	0.00312	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000375	0.00311	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MTNR1B—gestational diabetes	0.000373	0.0031	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—MTNR1B—gestational diabetes	0.000371	0.00308	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—MTNR1B—gestational diabetes	0.000366	0.00304	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—RBP4—gestational diabetes	0.000363	0.00302	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GGCT—gestational diabetes	0.000363	0.00302	CbGpPWpGaD
Droxidopa—DDC—Metabolism—CYP19A1—gestational diabetes	0.000358	0.00297	CbGpPWpGaD
Droxidopa—PAH—Disease—FGF2—gestational diabetes	0.000351	0.00292	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—MTNR1B—gestational diabetes	0.000347	0.00288	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—MTNR1B—gestational diabetes	0.000341	0.00283	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000334	0.00277	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GLS2—gestational diabetes	0.000317	0.00264	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—MTNR1B—gestational diabetes	0.00031	0.00258	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—LEPR—gestational diabetes	0.000307	0.00255	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—MTNR1B—gestational diabetes	0.000303	0.00252	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—MTNR1B—gestational diabetes	0.000282	0.00234	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—LEPR—gestational diabetes	0.00028	0.00232	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—LEPR—gestational diabetes	0.000277	0.0023	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—LEPR—gestational diabetes	0.000274	0.00227	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—LEPR—gestational diabetes	0.000259	0.00215	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—LEPR—gestational diabetes	0.000255	0.00212	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MTNR1B—gestational diabetes	0.000243	0.00202	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RBP4—gestational diabetes	0.000237	0.00197	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—LEPR—gestational diabetes	0.000226	0.00188	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MTNR1B—gestational diabetes	0.000221	0.00184	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MTNR1B—gestational diabetes	0.000219	0.00182	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MTNR1B—gestational diabetes	0.000216	0.0018	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RBP4—gestational diabetes	0.000216	0.00179	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—NAMPT—gestational diabetes	0.000214	0.00178	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RBP4—gestational diabetes	0.000214	0.00177	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GCK—gestational diabetes	0.000213	0.00177	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RBP4—gestational diabetes	0.000211	0.00175	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—LEPR—gestational diabetes	0.00021	0.00175	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MTNR1B—gestational diabetes	0.000205	0.0017	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MTNR1B—gestational diabetes	0.000202	0.00167	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RBP4—gestational diabetes	0.0002	0.00166	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RBP4—gestational diabetes	0.000196	0.00163	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MTNR1B—gestational diabetes	0.000179	0.00149	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RBP4—gestational diabetes	0.000174	0.00145	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—NAMPT—gestational diabetes	0.000174	0.00144	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GCK—gestational diabetes	0.000173	0.00144	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MTNR1B—gestational diabetes	0.000166	0.00138	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—LEP—gestational diabetes	0.000166	0.00138	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RBP4—gestational diabetes	0.000162	0.00135	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—CYP19A1—gestational diabetes	0.000156	0.00129	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—CYP19A1—gestational diabetes	0.000126	0.00105	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—FGF2—gestational diabetes	0.000126	0.00105	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—LEP—gestational diabetes	0.000108	0.000896	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—LEP—gestational diabetes	9.83e-05	0.000817	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—LEP—gestational diabetes	9.74e-05	0.000809	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—LEP—gestational diabetes	9.62e-05	0.000799	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—LEP—gestational diabetes	9.1e-05	0.000756	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—LEP—gestational diabetes	8.95e-05	0.000744	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—FGF2—gestational diabetes	8.2e-05	0.000681	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—LEP—gestational diabetes	7.95e-05	0.000661	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—FGF2—gestational diabetes	7.47e-05	0.00062	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—FGF2—gestational diabetes	7.4e-05	0.000615	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—LEP—gestational diabetes	7.39e-05	0.000614	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—FGF2—gestational diabetes	7.3e-05	0.000607	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—FGF2—gestational diabetes	6.91e-05	0.000574	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—FGF2—gestational diabetes	6.8e-05	0.000565	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—FGF2—gestational diabetes	6.04e-05	0.000502	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—FGF2—gestational diabetes	5.61e-05	0.000466	CbGpPWpGaD
